Experts know that in people younger than 65, having elevated levels of cholesterol in blood can increase your jeopardy for strokes and heart attacks. On the other hand, in people aged 80 and older, scientists have not methodically studied impact of high cholesterol on your capability of functioning well, heart disease, or your jeopardy for death.
In fact, some study displays that a lower level of supposed “bad” cholesterol and a higher amount of total cholesterol may be useful in preserving your life for longer and defending your capability of performing daily activities.
What’s more, it seems that having low cholesterol is connected to a higher jeopardy of death from respiratory disease, cancer, and accidents in adults more than 80 years and older. It also seems that the advantages of taking medicines dubbed statins, which reduces cholesterol, might reduce as people grow. Scientists even have a phrase for this occurrence—risk factor paradox.
On a related note, a new drug-delivery “metal-synchronized” tech possibly can be employed to supplement the standard treatment for hypothyroidism, which impacts almost 10 Million people in the U.S. and many more patients all over the world. This news was as per to results of a study posted this month in the journal Thyroid.
Scientists at Rush University Medical Center have been following an enhanced therapy for a number of hypothyroid patients who do not respond well to the standard treatment. Now, their research into how thyroid hormones provided in tablets are metabolized & absorbed by the body recommends that a metal-synchronized molecule can prove to be a more effectual treatment for all hypothyroid patients. This is as per Dr. Antonio Bianco, who is a professor at the University of Chicago for medicine and was earlier a clinician & researcher at Rush.